Advertisement

Vitamin D, Calcium, and Cardiovascular Disease: A“D”vantageous or “D”etrimental? An Era of Uncertainty

  • Kathleen Chin
  • Lawrence J. Appel
  • Erin D. MichosEmail author
Coronary Heart Disease (S. Virani and S. Naderi, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Coronary Heart Disease

Abstract

While the function of vitamin D in regulating calcium homeostasis is well established, there has been growing interest in its role in the prevention of numerous chronic diseases, including cardiovascular disease (CVD). There is mounting epidemiological evidence suggesting that vitamin D deficiency is linked to increased CVD risk. However, the results of previous vitamin D supplementation trials have yielded mixed results in regards to cardiovascular health, and the results of ongoing large-scale randomized controlled trials are not yet available. Further complicating the issue, calcium supplementation, which is often prescribed concurrently with vitamin D, has been associated with increased CVD risk in some (but not all) studies. Thus, it is currently unclear whether vitamin D supplements, particularly for those that are deficient, can help prevent the development of CVD. In addition, there has not been uniform consensus regarding the threshold of 25-hydroxyvitamin D levels that constitutes “sufficiency” across organizational guidelines. This review will provide an update on the most recent evidence regarding the effects of vitamin D and calcium supplements on CVD clinical outcomes, summarize ongoing vitamin D trials, and discuss the current but remarkably disparate recommendations regarding vitamin D deficiency screening and supplementation.

Keywords

Vitamin D Calcium Supplementation Cardiovascular disease Prevention 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

Kathleen Chin and Lawrence J. Appel declare that they have no conflict of interest.

Erin D. Michos reports receiving an honorarium from Siemens Diagnostics (modest) for work unrelated to this topic.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Funding

Erin Michos is supported by a grant R01NS072243 from NIH/NINDS and the Blumenthal Scholars Award in Preventive Cardiology. Kathleen Chin was funded by the Hopkins Scholars Program.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Wong ND. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol. 2014;11(5):276–89.CrossRefPubMedGoogle Scholar
  2. 2.
    Wang L, Song Y, Manson JE, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012;5(6):819–29.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S–6.PubMedGoogle Scholar
  4. 4.
    Jorde R, Sollid ST, Svartberg J, et al. Vitamin D 20,000 IU per week for five years does not prevent progression from prediabetes to diabetes. J Clin Endocrinol Metab. 2016;101(4):1647–55.CrossRefPubMedGoogle Scholar
  5. 5.
    • Golzarand M, Shab-Bidar S, Koochakpoor G, Speakman JR, Djafarian K. Effect of vitamin D3 supplementation on blood pressure in adults: an updated meta-analysis. Nutr Metab Cardiovasc Dis. 2016;26(8):663–73. This recent meta-analysis of 30 RCTs found variable effects of vitamin D supplementation on blood pressure overall, but provides some evidence that vitamin D supplementation might be an effective intervention in specific populations, including older and hypertensive individuals. CrossRefPubMedGoogle Scholar
  6. 6.
    Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. The Lancet Diabet Endocrinol. 2014;2(4):307–20.CrossRefGoogle Scholar
  7. 7.
    Ford JA, MacLennan GS, Avenell A, et al. Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr. 2014;100(3):746–55.CrossRefPubMedGoogle Scholar
  8. 8.
    Hsia J, Heiss G, Ren H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115(7):846–54.CrossRefPubMedGoogle Scholar
  9. 9.
    Prentice RL, Pettinger MB, Jackson RD, et al. Health risks and benefits from calcium and vitamin D supplementation: Women’s Health Initiative clinical trial and cohort study. Osteoporos Int. 2013;24(2):567–80.CrossRefPubMedGoogle Scholar
  10. 10.
    Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007;370(9588):657–66.CrossRefPubMedGoogle Scholar
  11. 11.
    Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ. 2011;342:d2040.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80(6 Suppl):1678S–88.PubMedGoogle Scholar
  13. 13.
    Schleicher RL, Sternberg MR, Lacher DA, et al. The vitamin D status of the US population from 1988 to 2010 using standardized serum concentrations of 25-hydroxyvitamin D shows recent modest increases. Am J Clin Nutr. 2016;104(2):454–61.CrossRefPubMedGoogle Scholar
  14. 14.
    Calvo MS, Whiting SJ. Survey of current vitamin D food fortification practices in the United States and Canada. J Steroid Biochem Mol Biol. 2013;136:211–3.CrossRefPubMedGoogle Scholar
  15. 15.
    Gahche J, Bailey R, Burt V, et al: Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994). NCHS Data Brief 2011(61):1-8.Google Scholar
  16. 16.
    MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985;76(4):1536–8.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Harris SS. Vitamin D and African Americans. J Nutr. 2006;136(4):1126–9.PubMedGoogle Scholar
  18. 18.
    Somjen D, Weisman Y, Kohen F, et al. 25-Hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation. 2005;111(13):1666–71.CrossRefPubMedGoogle Scholar
  19. 19.
    Zehnder D, Bland R, Chana RS, et al. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol. 2002;13(3):621–9.PubMedGoogle Scholar
  20. 20.
    Monkawa T, Yoshida T, Hayashi M, Saruta T. Identification of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression in macrophages. Kidney Int. 2000;58(2):559–68.CrossRefPubMedGoogle Scholar
  21. 21.
    Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19(2):73–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab. 1986;63(4):954–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Yousefzadeh P, Shapses SA, Wang X. Vitamin D binding protein impact on 25-hydroxyvitamin D levels under different physiologic and pathologic conditions. Int J Endocrinol. 2014;2014:981581.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Lutsey PL, Michos ED, Misialek JR, et al. Race and vitamin D binding protein gene polymorphisms modify the association of 25-hydroxyvitamin D and incident heart failure: the ARIC (Atherosclerosis Risk in Communities) study. JACC Heart Fail. 2015;3(5):347–56.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Michos ED, Misialek JR, Selvin E, et al. 25-Hydroxyvitamin D levels, vitamin D binding protein gene polymorphisms and incident coronary heart disease among whites and blacks: the ARIC study. Atherosclerosis. 2015;241(1):12–7.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Robinson-Cohen C, Hoofnagle AN, Ix JH, et al. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA. 2013;310(2):179–88.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Michos ED, Reis JP, Post WS, et al. 25-Hydroxyvitamin D deficiency is associated with fatal stroke among Whites but not Blacks: the NHANES-III linked mortality files. Nutrition. 2012;28(4):367–71.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Powe CE, Evans MK, Wenger J, et al. Vitamin D-binding protein and vitamin D status of Black Americans and White Americans. N Engl J Med. 2013;369(21):1991–2000.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Schneider AL, Lutsey PL, Selvin E, et al. Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study. Eur J Neurol. 2015;22(8):1220–7.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Henderson CM, Lutsey PL, Misialek JR, et al. Measurement by a novel LC-MS/MS methodology reveals similar serum concentrations of vitamin D-binding protein in Blacks and Whites. Clin Chem. 2016;62(1):179–87.CrossRefPubMedGoogle Scholar
  31. 31.
    Denburg MR, Hoofnagle AN, Sayed S, et al. Comparison of two ELISA methods and mass spectrometry for measurement of vitamin D-binding protein: implications for the assessment of bioavailable vitamin D concentrations across genotypes. J Bone Miner Res. 2016;31(6):1128–36.CrossRefPubMedGoogle Scholar
  32. 32.
    Burgaz A, Orsini N, Larsson SC, Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens. 2011;29(4):636–45.CrossRefPubMedGoogle Scholar
  33. 33.
    Kunutsor SK, Apekey TA, Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol. 2013;28(3):205–21.CrossRefPubMedGoogle Scholar
  34. 34.
    Jorde R, Figenschau Y, Emaus N, Hutchinson M, Grimnes G. Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension. 2010;55(3):792–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Vimaleswaran KS, Cavadino A, Berry DJ, et al. Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabet Endocrinol. 2014;2(9):719–29.CrossRefGoogle Scholar
  36. 36.
    Zhang Y, Kong J, Deb DK, Chang A, Li YC. Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system. J Am Soc Nephrol. 2010;21(6):966–73.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int. 2008;74(2):170–9.CrossRefPubMedGoogle Scholar
  38. 38.
    • Grubler MR, Gaksch M, Kienreich K, et al. Effects of vitamin D supplementation on plasma aldosterone and renin—a randomized placebo-controlled trial. J Clin Hypertens (Greenwich). 2016;18(7):608–13. This recent randomized controlled trial provides evidence that vitamin D supplementation improves HbA1c levels, although not fasting glucose, in hypertensive patients. Although limited by sample size and study duration, it suggests that there is a role for vitamin D intervention in improving cardiovascular risk factors. CrossRefGoogle Scholar
  39. 39.
    Forman JP, Scott JB, Ng K, et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension. 2013;61(4):779–85.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Beveridge LA, Struthers AD, Khan F, et al. Effect of vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data. JAMA Intern Med. 2015;175(5):745–54.CrossRefPubMedGoogle Scholar
  41. 41.
    Kunutsor SK, Burgess S, Munroe PB, Khan H. Vitamin D and high blood pressure: causal association or epiphenomenon? Eur J Epidemiol. 2014;29(1):1–14.CrossRefPubMedGoogle Scholar
  42. 42.
    Arora P, Song Y, Dusek J, et al. Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation. 2015;131(3):254–62.CrossRefPubMedGoogle Scholar
  43. 43.
    Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79(5):820–5.PubMedGoogle Scholar
  44. 44.
    Kayaniyil S, Vieth R, Retnakaran R, et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care. 2010;33(6):1379–81.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Afzal S, Bojesen SE, Nordestgaard BG. Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin Chem. 2013;59(2):381–91.CrossRefPubMedGoogle Scholar
  46. 46.
    Reis JP, Michos ED, Selvin E, Pankow JS, Lutsey PL. Race, vitamin D-binding protein gene polymorphisms, 25-hydroxyvitamin D, and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Am J Clin Nutr. 2015;101(6):1232–40.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Grubler MR, Gaksch M, Kienreich K, et al: Effects of vitamin D supplementation on glycated haemoglobin and fasting glucose levels in hypertensive patients: a randomized controlled trial. Diabetes Obes Metab 2016Google Scholar
  48. 48.
    George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med. 2012;29(8):e142–50.CrossRefPubMedGoogle Scholar
  49. 49.
    Seida JC, Mitri J, Colmers IN, et al. Clinical review: effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014;99(10):3551–60.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Nigil Haroon N, Anton A, John J, Mittal M. Effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes: a systematic review of interventional studies. J Diabet Metab Disord. 2015;14:3.CrossRefGoogle Scholar
  51. 51.
    Jamka M, Wozniewicz M, Jeszka J, Mardas M, Bogdanski P, Stelmach-Mardas M. The effect of vitamin D supplementation on insulin and glucose metabolism in overweight and obese individuals: systematic review with meta-analysis. Sci Rep. 2015;5:16142.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Norman PE, Powell JT. Vitamin D and cardiovascular disease. Circ Res. 2014;114(2):379–93.CrossRefPubMedGoogle Scholar
  53. 53.
    Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res. 2014;7:69–87.PubMedPubMedCentralGoogle Scholar
  54. 54.
    Beilfuss J, Berg V, Sneve M, Jorde R, Kamycheva E. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine. 2012;60(3):870–4.CrossRefPubMedGoogle Scholar
  55. 55.
    Jamka M, Wozniewicz M, Walkowiak J, Bogdanski P, Jeszka J, Stelmach-Mardas M: The effect of vitamin D supplementation on selected inflammatory biomarkers in obese and overweight subjects: a systematic review with meta-analysis. Eur J Nutr 2015.Google Scholar
  56. 56.
    Gupta GK, Agrawal T, DelCore MG, Mohiuddin SM, Agrawal DK. Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hypercholesterolemic swine. Exp Mol Pathol. 2012;93(1):82–90.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Gardner DG, Chen S, Glenn DJ. Vitamin D and the heart. Am J Physiol Regul Integr Comp Physiol. 2013;305(9):R969–77.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Bae S, Singh SS, Yu H, Lee JY, Cho BR, Kang PM. Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction. J Appl Physiol (1985). 2013;114(8):979–87.CrossRefGoogle Scholar
  59. 59.
    van Ballegooijen AJ, Snijder MB, Visser M, et al. Vitamin D in relation to myocardial structure and function after eight years of follow-up: the Hoorn study. Ann Nutr Metab. 2012;60(1):69–77.CrossRefPubMedGoogle Scholar
  60. 60.
    Rautiainen S, Wang L, Manson JE, Sesso HD. The role of calcium in the prevention of cardiovascular disease—a review of observational studies and randomized clinical trials. Curr Atheroscler Rep. 2013;15(11):362.CrossRefPubMedGoogle Scholar
  61. 61.
    Bristow SM, Gamble GD, Stewart A, Horne AM, Reid IR. Acute effects of calcium supplements on blood pressure and blood coagulation: secondary analysis of a randomised controlled trial in post-menopausal women. Br J Nutr. 2015;114(11):1868–74.CrossRefPubMedGoogle Scholar
  62. 62.
    Spence LA, Weaver CM. Calcium intake, vascular calcification, and vascular disease. Nutr Rev. 2013;71(1):15–22.CrossRefPubMedGoogle Scholar
  63. 63.
    Anderson JJ, Klemmer PJ. Risk of high dietary calcium for arterial calcification in older adults. Nutrients. 2013;5(10):3964–74.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Mangano KM, Walsh SJ, Insogna KL, Kenny AM, Kerstetter JE. Calcium intake in the United States from dietary and supplemental sources across adult age groups: new estimates from the National Health and Nutrition Examination Survey 2003–2006. J Am Diet Assoc. 2011;111(5):687–95.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53–8.CrossRefPubMedGoogle Scholar
  66. 66.
    Gallagher JC, Smith LM, Yalamanchili V. Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women. Menopause. 2014;21(11):1173–80.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Garland CF, Kim JJ, Mohr SB, et al. Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D. Am J Public Health. 2014;104(8):e43–50.CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Schottker B, Jorde R, Peasey A, et al. Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ. 2014;348:g3656.CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629–37.CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Brondum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG. 25-Hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol. 2012;32(11):2794–802.CrossRefPubMedGoogle Scholar
  71. 71.
    Aleksova A, Belfiore R, Carriere C, et al. Vitamin D deficiency in patients with acute myocardial infarction: an Italian single-center study. Int J Vitam Nutr Res. 2015;85(1-2):23–30.CrossRefPubMedGoogle Scholar
  72. 72.
    Chowdhury R, Stevens S, Ward H, Chowdhury S, Sajjad A, Franco OH. Circulating vitamin D, calcium and risk of cerebrovascular disease: a systematic review and meta-analysis. Eur J Epidemiol. 2012;27(8):581–91.CrossRefPubMedGoogle Scholar
  73. 73.
    •• Durup D, Jorgensen HL, Christensen J, et al. A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality: the CopD study. J Clin Endocrinol Metab. 2015;100(6):2339–46. This recent, large observational cohort study adds to the debate surrounding optimal 25(OH)D levels, as the reverse J-shaped association found between 25(OH)D and CVD mortality highlights the need to examine the effects of high 25(OH)D levels on CVD health. CrossRefPubMedGoogle Scholar
  74. 74.
    Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.CrossRefPubMedGoogle Scholar
  75. 75.
    Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690–3.PubMedGoogle Scholar
  76. 76.
    •• Manousaki D, Mokry LE, Ross S, Goltzman D, Richards JB: Mendelian randomization studies do not support a role for vitamin D in coronary artery disease. Circ Cardiovasc Genet 2016. This recent Mendelian randomization study provides evidence that genetically low vitamin D levels is not causally associated with increased coronary artery disease risk. This corroborates results from other randomziation studies, suggesting that the association between 25(OH)D and cardiovascular outcomes seen in observational studies may be due to confounding or reverse causation.Google Scholar
  77. 77.
    Afzal S, Brondum-Jacobsen P, Bojesen SE, Nordestgaard BG. Genetically low vitamin D concentrations and increased mortality: Mendelian randomisation analysis in three large cohorts. BMJ. 2014;349:g6330.CrossRefPubMedPubMedCentralGoogle Scholar
  78. 78.
    Paik JM, Curhan GC, Sun Q, et al. Calcium supplement intake and risk of cardiovascular disease in women. Osteoporos Int. 2014;25(8):2047–56.CrossRefPubMedPubMedCentralGoogle Scholar
  79. 79.
    •• Raffield LM, Agarwal S, Hsu FC, et al: The association of calcium supplementation and incident cardiovascular events in the Multi-ethnic Study of Atherosclerosis (MESA). Nutr Metab Cardiovasc Dis 2016. This recent observational study is important as it provides reassuring evidence that neither calcium supplementation nor dietary calcium is associated with incident CVD events, providing further insight into the controversy of calcium’s potential role in CVD risk.Google Scholar
  80. 80.
    •• Anderson JJB, Kruszka B, Delaney JAC, et al: Calcium intake and the risk of coronary arterial calcification and its progression among older adults: 10-year follow-up of the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Heart Assoc 2016;11:5(10). This recent observational study provides evidence that dietary calcium may have a protective effect against incident CVD, but found an association between supplemental calcium and coronary artery calcification. Combined with the results from Raffield et al., it underlines the importance of future research to clarify the uncertainty in this field.Google Scholar
  81. 81.
    Wang X, Chen H, Ouyang Y, et al. Dietary calcium intake and mortality risk from cardiovascular disease and all causes: a meta-analysis of prospective cohort studies. BMC Med. 2014;12:158.CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Pradhan AD, Manson JE, Pt B. Update on the Vitamin D and OmegA-3 trial (VITAL). J Steroid Biochem Mol Biol. 2016;155:252–6.CrossRefPubMedGoogle Scholar
  83. 83.
    Neale RE, Armstrong BK, Baxter C, et al. The D-Health Trial: a randomized trial of vitamin D for prevention of mortality and cancer. Contemp Clin Trials. 2016;48:83–90.CrossRefPubMedGoogle Scholar
  84. 84.
    Scragg R, Waayer D, Stewart AW, et al: The Vitamin D Assessment (ViDA) Study: design of a randomized controlled trial of vitamin D supplementation for the prevention of cardiovascular disease, acute respiratory infection, falls and non-vertebral fractures. J Steroid Biochem Mol Biol 2015.Google Scholar
  85. 85.
    Vitamin D and Mortality in Heart Failure (EVITA) [https://clinicaltrials.gov/ct2/show/NCT01326650]
  86. 86.
    Vitamin D and Longevity (VIDAL) Trial: randomised feasibility study [http://www.isrctn.com/ISRCTN46328341]
  87. 87.
    Pittas AG, Dawson-Hughes B, Sheehan PR, et al. Rationale and design of the vitamin D and type 2 diabetes (D2d) study: a diabetes prevention trial. Diabetes Care. 2014;37(12):3227–34.CrossRefPubMedPubMedCentralGoogle Scholar
  88. 88.
    DO-HEALTH/Vitamin D3-Omega3-Home Exercise-Healthy Ageing and Longevity Trial (DO-HEALTH) [https://clinicaltrials.gov/ct2/show/study/NCT01745263]
  89. 89.
    Finnish Vitamin D Trial (FIND) [https://clinicaltrials.gov/ct2/show/NCT01463813]
  90. 90.
    Mann MC, Hobbs AJ, Hemmelgarn BR, Roberts DJ, Ahmed SB, Rabi DM. Effect of oral vitamin D analogs on mortality and cardiovascular outcomes among adults with chronic kidney disease: a meta-analysis. Clin Kidney J. 2015;8(1):41–8.CrossRefPubMedGoogle Scholar
  91. 91.
    •• Witte KK, Byrom R, Gierula J, et al. Effects of vitamin D on cardiac function in patients with chronic HF: the VINDICATE study. J Am Coll Cardiol. 2016;67(22):2593–603. This recent randomized controlled trial is important because it provides evidence that vitamin D supplementation improved left ventricular ejection fraction and promote cardiac remodeling in heart failure patients. While these measures were not the primary outcome, this suggests that vitamin D supplementation may be beneficial to cardiovascular health. CrossRefPubMedPubMedCentralGoogle Scholar
  92. 92.
    Jiang WL, Gu HB, Zhang YF, Xia QQ, Qi J, Chen JC. Vitamin D supplementation in the treatment of chronic heart failure: a meta-analysis of randomized controlled trials. Clin Cardiol. 2016;39(1):56–61.CrossRefPubMedGoogle Scholar
  93. 93.
    Radford LT, Bolland MJ, Mason B, et al. The Auckland calcium study: 5-year post-trial follow-up. Osteoporos Int. 2014;25(1):297–304.CrossRefPubMedGoogle Scholar
  94. 94.
    Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691.CrossRefPubMedPubMedCentralGoogle Scholar
  95. 95.
    Lewis JR, Zhu K, Thompson PL, Prince RL. The effects of 3 years of calcium supplementation on common carotid artery intimal medial thickness and carotid atherosclerosis in older women: an ancillary study of the CAIFOS randomized controlled trial. J Bone Miner Res. 2014;29(3):534–41.CrossRefPubMedGoogle Scholar
  96. 96.
    Challoumas D, Stavrou A, Pericleous A, Dimitrakakis G. Effects of combined vitamin D—calcium supplements on the cardiovascular system: should we be cautious? Atherosclerosis. 2015;238(2):388–98.CrossRefPubMedGoogle Scholar
  97. 97.
    American Geriatrics Society Workgroup on Vitamin DSfOA. Recommendations abstracted from the American Geriatrics Society consensus statement on vitamin D for prevention of falls and their consequences. J Am Geriatr Soc. 2014;62(1):147–52.CrossRefGoogle Scholar
  98. 98.
    LeFevre ML. Force USPST: screening for vitamin D deficiency in adults: U.S. Preventive services task force recommendation statement. Ann Intern Med. 2015;162(2):133–40.CrossRefPubMedGoogle Scholar
  99. 99.
    Cosman F, de Beur SJ, LeBoff MS, et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359–81.CrossRefPubMedPubMedCentralGoogle Scholar
  100. 100.
    SACN Vitamin D and Health Report. In.: Scientific Advisory Committee on Nutrition; 2016.Google Scholar
  101. 101.
    Vitamin D: increasing supplement use among at-risk groups. In.: National Institute for Health and Care Excellence; 2014.Google Scholar
  102. 102.
    Pilz S, Verheyen N, Grubler MR, Tomaschitz A, Marz W. Vitamin D and cardiovascular disease prevention. Nat Rev Cardiol. 2016;13(7):404–17.CrossRefPubMedGoogle Scholar
  103. 103.
    Rosen CJ, Abrams SA, Aloia JF, et al. IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab. 2012;97(4):1146–52.CrossRefPubMedGoogle Scholar
  104. 104.
    Huang KE, Milliron BJ, Davis SA, Feldman SR. Surge in US outpatient vitamin D deficiency diagnoses: National Ambulatory Medical Care Survey analysis. South Med J. 2014;107(4):214–7.CrossRefPubMedPubMedCentralGoogle Scholar
  105. 105.
    Tarn DM, Paterniti DA, Wenger NS. Provider recommendations in the face of scientific uncertainty: an analysis of audio-recorded discussions about vitamin D. J Gen Intern Med. 2016;31(8):909–17.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Kathleen Chin
    • 1
  • Lawrence J. Appel
    • 2
    • 3
  • Erin D. Michos
    • 1
    • 2
    • 3
    Email author
  1. 1.Ciccarone Center for the Prevention of Heart Disease, Division of CardiologyJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.Welch Center for Prevention, Epidemiology, and Clinical ResearchJohns Hopkins University School of MedicineBaltimoreUSA
  3. 3.Department of EpidemiologyJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA

Personalised recommendations